The Peptide Center
Register / Sign in

Reference library

Peptide guides

Browse clear, source-aware overviews organized across six areas of study.

89 published guides

  1. metabolic-health5-Amino-1MQAn evidence-first reference for reading claims and source material about 5-Amino-1MQ.View guide
  2. metabolic-health5-Amino-1MQ / SLU-PP-332An evidence-first reference for reading claims and source material about 5-Amino-1MQ / SLU-PP-332.View guide
  3. healthy-agingAlpha-Klotho mAbAn evidence-first reference for reading claims and source material about Alpha-Klotho mAb.View guide
  4. metabolic-healthAOD-9604An evidence-first reference for reading claims and source material about AOD-9604.View guide
  5. metabolic-healthAOD-9604: interpreting a fragment-peptide claimA framework for evaluating evidence and regulatory claims around an hGH-fragment research compound.View guide
  6. recovery-repairARA-290An evidence-first reference for reading claims and source material about ARA-290.View guide
  7. metabolic-healthATX-304An evidence-first reference for reading claims and source material about ATX-304.View guide
  8. metabolic-healthB7-33: an early-stage research overviewWhy preclinical pathway research should not be confused with an established intervention.View guide
  9. metabolic-healthBAM15An evidence-first reference for reading claims and source material about BAM15.View guide
  10. cognitive-wellnessBDNFAn evidence-first reference for reading claims and source material about BDNF.View guide
  11. recovery-repairBPC-157An evidence-first reference for reading claims and source material about BPC-157.View guide
  12. recovery-repairBPC-157: an evidence-first guideA conservative review of what laboratory findings can and cannot tell us about BPC-157.View guide
  13. metabolic-healthCagrilintideAn evidence-first reference for reading claims and source material about Cagrilintide.View guide
  14. metabolic-healthCagrilintide / GLP-1An evidence-first reference for reading claims and source material about Cagrilintide / GLP-1.View guide
  15. metabolic-healthCagrilintide: evaluating investigational product claimsA careful way to separate interest in a molecule from evidence, approval, and product claims.View guide
  16. recovery-repairCardiogenAn evidence-first reference for reading claims and source material about Cardiogen.View guide
  17. recovery-repairCartalaxAn evidence-first reference for reading claims and source material about Cartalax.View guide
  18. performance-vitalityCJC-1295 No DACAn evidence-first reference for reading claims and source material about CJC-1295 No DAC.View guide
  19. performance-vitalityCJC-1295 No DAC / IpamorelinAn evidence-first reference for reading claims and source material about CJC-1295 No DAC / Ipamorelin.View guide
  20. performance-vitalityCJC-1295 With DACAn evidence-first reference for reading claims and source material about CJC-1295 With DAC.View guide
  21. performance-vitalityCJC-1295: separating endocrine research from outcome claimsHow to assess research on a growth-hormone–releasing hormone analogue without overreading biomarker changes.View guide
  22. performance-vitalityCJC-1295: separating mechanism from outcomeA framework for evaluating performance claims without treating a biological mechanism as proof of benefit.View guide
  23. recovery-repairCurcuminAn evidence-first reference for reading claims and source material about Curcumin.View guide
  24. cognitive-wellnessDihexaAn evidence-first reference for reading claims and source material about Dihexa.View guide
  25. cognitive-wellnessDihexa / Tesofensine / BPC-157An evidence-first reference for reading claims and source material about Dihexa / Tesofensine / BPC-157.View guide
  26. cognitive-wellnessDSIPAn evidence-first reference for reading claims and source material about DSIP.View guide
  27. healthy-agingEpithalonAn evidence-first reference for reading claims and source material about Epithalon.View guide
  28. healthy-agingFLGR242An evidence-first reference for reading claims and source material about FLGR242.View guide
  29. performance-vitalityFollistatin 344An evidence-first reference for reading claims and source material about Follistatin 344.View guide
  30. healthy-agingFOXO4-DRIAn evidence-first reference for reading claims and source material about FOXO4-DRI.View guide
  31. recovery-repairGHK-CuAn evidence-first reference for reading claims and source material about GHK-Cu.View guide
  32. recovery-repairGHK-Cu: a research-context guideHow to read the GHK-Cu literature without turning mechanisms or models into clinical promises.View guide
  33. performance-vitalityGHRP-2An evidence-first reference for reading claims and source material about GHRP-2.View guide
  34. performance-vitalityGHRP-6An evidence-first reference for reading claims and source material about GHRP-6.View guide
  35. recovery-repairGLOWAn evidence-first reference for reading claims and source material about GLOW.View guide
  36. metabolic-healthGLP-1 RAn evidence-first reference for reading claims and source material about GLP-1 R.View guide
  37. metabolic-healthGLP-1 SAn evidence-first reference for reading claims and source material about GLP-1 S.View guide
  38. metabolic-healthGLP-1 S / SLU-PP-332An evidence-first reference for reading claims and source material about GLP-1 S / SLU-PP-332.View guide
  39. metabolic-healthGLP-1 TAn evidence-first reference for reading claims and source material about GLP-1 T.View guide
  40. healthy-agingGonadorelinAn evidence-first reference for reading claims and source material about Gonadorelin.View guide
  41. performance-vitalityGrowth-hormone secretagogues: mechanism is not a clinical outcomeHow to evaluate claims involving GHRP compounds, biomarkers, body composition, and recovery.View guide
  42. performance-vitalityHexarelinAn evidence-first reference for reading claims and source material about Hexarelin.View guide
  43. performance-vitalityIGF-1 LR3An evidence-first reference for reading claims and source material about IGF-1 LR3.View guide
  44. performance-vitalityIpamorelinAn evidence-first reference for reading claims and source material about Ipamorelin.View guide
  45. performance-vitalityIpamorelin: what a signaling claim does not establishA plain-language guide to evaluating ipamorelin claims and evidence quality.View guide
  46. performance-vitalityIpamorelin: what evidence quality meansQuestions to ask before accepting claims about body composition, recovery, or vitality.View guide
  47. healthy-agingKisspeptinAn evidence-first reference for reading claims and source material about Kisspeptin.View guide
  48. healthy-agingKisspeptin: reproductive physiology and research literacyA research overview that keeps physiology, clinical evidence, and treatment claims separate.View guide
  49. healthy-agingKisspeptin: research context, identity, and evidence limitsA framework for reviewing a signaling-peptide claim without turning early research into medical guidance.View guide
  50. recovery-repairKLOWAn evidence-first reference for reading claims and source material about KLOW.View guide
  51. recovery-repairKPVAn evidence-first reference for reading claims and source material about KPV.View guide
  52. healthy-agingLL-37An evidence-first reference for reading claims and source material about LL-37.View guide
  53. healthy-agingLL-37 ComplexAn evidence-first reference for reading claims and source material about LL-37 Complex.View guide
  54. healthy-agingLL-37: antimicrobial-peptide research without hypeA guide to distinguishing antimicrobial mechanism research from clinical safety or treatment claims.View guide
  55. recovery-repairMelanotan IIAn evidence-first reference for reading claims and source material about Melanotan II.View guide
  56. cognitive-wellnessMethylene Blue / MethylliberineAn evidence-first reference for reading claims and source material about Methylene Blue / Methylliberine.View guide
  57. performance-vitalityMK-677An evidence-first reference for reading claims and source material about MK-677.View guide
  58. metabolic-healthMOTS-cAn evidence-first reference for reading claims and source material about MOTS-c.View guide
  59. metabolic-healthMOTS-c: mitochondrial signaling research in contextHow to understand a mitochondrial-derived peptide as an active research topic, not a shortcut to a health claim.View guide
  60. healthy-agingNAD+An evidence-first reference for reading claims and source material about NAD+.View guide
  61. cognitive-wellnessOxytocinAn evidence-first reference for reading claims and source material about Oxytocin.View guide
  62. cognitive-wellnessPE-22-28An evidence-first reference for reading claims and source material about PE-22-28.View guide
  63. healthy-agingPNC-28An evidence-first reference for reading claims and source material about PNC-28.View guide
  64. healthy-agingPT-141An evidence-first reference for reading claims and source material about PT-141.View guide
  65. metabolic-healthRetatrutide: why regulatory status and study status are differentHow to distinguish an investigational study record from an approved medicine or lawful compounded product.View guide
  66. cognitive-wellnessSelankAn evidence-first reference for reading claims and source material about Selank.View guide
  67. cognitive-wellnessSelank: interpreting cognitive and mood claimsA cautious guide to regional approvals, study quality, and claims made in the United States.View guide
  68. metabolic-healthSemaglutide: approved medicines and unapproved versionsA regulatory guide to branded FDA-approved medicines, compounded preparations, and unapproved products.View guide
  69. cognitive-wellnessSemaxAn evidence-first reference for reading claims and source material about Semax.View guide
  70. performance-vitalitySermorelinAn evidence-first reference for reading claims and source material about Sermorelin.View guide
  71. metabolic-healthSLU-PP-332An evidence-first reference for reading claims and source material about SLU-PP-332.View guide
  72. healthy-agingSS-31An evidence-first reference for reading claims and source material about SS-31.View guide
  73. recovery-repairTB-500An evidence-first reference for reading claims and source material about TB-500.View guide
  74. recovery-repairTB-500 and thymosin beta-4: know the distinctionWhy related names do not make research compounds interchangeable with an approved medicine.View guide
  75. healthy-agingTesamorelinAn evidence-first reference for reading claims and source material about Tesamorelin.View guide
  76. performance-vitalityTesamorelin / GHRP-2 / MGF / IpamorelinAn evidence-first reference for reading claims and source material about Tesamorelin / GHRP-2 / MGF / Ipamorelin.View guide
  77. performance-vitalityTesamorelin / IpamorelinAn evidence-first reference for reading claims and source material about Tesamorelin / Ipamorelin.View guide
  78. performance-vitalityTesamorelin / MGF / IpamorelinAn evidence-first reference for reading claims and source material about Tesamorelin / MGF / Ipamorelin.View guide
  79. healthy-agingTesamorelin: why the labeled indication mattersAn example of why FDA approval for one defined use does not support broader healthy-aging claims.View guide
  80. metabolic-healthTesofensineAn evidence-first reference for reading claims and source material about Tesofensine.View guide
  81. cognitive-wellnessTesofensine / DihexaAn evidence-first reference for reading claims and source material about Tesofensine / Dihexa.View guide
  82. healthy-agingThymagenAn evidence-first reference for reading claims and source material about Thymagen.View guide
  83. healthy-agingThymalinAn evidence-first reference for reading claims and source material about Thymalin.View guide
  84. healthy-agingThymosin Alpha-1An evidence-first reference for reading claims and source material about Thymosin Alpha-1.View guide
  85. healthy-agingThymosin Alpha-1 ComplexAn evidence-first reference for reading claims and source material about Thymosin Alpha-1 Complex.View guide
  86. metabolic-healthTirzepatide: indication and product status matterHow to separate evidence for an FDA-approved branded product from claims about other preparations.View guide
  87. recovery-repairVIP / BPC-157An evidence-first reference for reading claims and source material about VIP / BPC-157.View guide
  88. metabolic-healthWeight Loss BlendAn evidence-first reference for reading claims and source material about Weight Loss Blend.View guide
  89. recovery-repairWolverine BlendAn evidence-first reference for reading claims and source material about Wolverine Blend.View guide

Research comparison

Compare cited research context

Compare neutral, source-linked facts—not dosing, protocols, or treatment advice.